nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Lamivudine—NME1—peripheral nervous system neoplasm	0.0258	0.931	CrCbGaD
Emtricitabine—DCK—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.0079	0.519	CbGdCrCtD
Emtricitabine—DCK—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.00731	0.481	CbGdCrCtD
Emtricitabine—Lamivudine—ABCB1—peripheral nervous system neoplasm	0.0019	0.0686	CrCbGaD
Emtricitabine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000805	0.000841	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000796	0.000832	CcSEcCtD
Emtricitabine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000795	0.000831	CcSEcCtD
Emtricitabine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000791	0.000826	CcSEcCtD
Emtricitabine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000789	0.000824	CcSEcCtD
Emtricitabine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000789	0.000824	CcSEcCtD
Emtricitabine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000785	0.00082	CcSEcCtD
Emtricitabine—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.000815	CcSEcCtD
Emtricitabine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000779	0.000814	CcSEcCtD
Emtricitabine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000779	0.000814	CcSEcCtD
Emtricitabine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000777	0.000812	CcSEcCtD
Emtricitabine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000774	0.000809	CcSEcCtD
Emtricitabine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000773	0.000807	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000772	0.000806	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000771	0.000805	CcSEcCtD
Emtricitabine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000769	0.000804	CcSEcCtD
Emtricitabine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000769	0.000803	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000767	0.000802	CcSEcCtD
Emtricitabine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.000797	CcSEcCtD
Emtricitabine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000763	0.000797	CcSEcCtD
Emtricitabine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000762	0.000796	CcSEcCtD
Emtricitabine—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000757	0.00079	CcSEcCtD
Emtricitabine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000756	0.00079	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000755	0.000788	CcSEcCtD
Emtricitabine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000754	0.000787	CcSEcCtD
Emtricitabine—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.000787	CcSEcCtD
Emtricitabine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000747	0.000781	CcSEcCtD
Emtricitabine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000745	0.000779	CcSEcCtD
Emtricitabine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000745	0.000779	CcSEcCtD
Emtricitabine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00074	0.000773	CcSEcCtD
Emtricitabine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000739	0.000772	CcSEcCtD
Emtricitabine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000733	0.000766	CcSEcCtD
Emtricitabine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000733	0.000766	CcSEcCtD
Emtricitabine—Rash—Topotecan—peripheral nervous system neoplasm	0.000733	0.000766	CcSEcCtD
Emtricitabine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000732	0.000765	CcSEcCtD
Emtricitabine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00073	0.000763	CcSEcCtD
Emtricitabine—Cough—Etoposide—peripheral nervous system neoplasm	0.000729	0.000762	CcSEcCtD
Emtricitabine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000729	0.000762	CcSEcCtD
Emtricitabine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000729	0.000762	CcSEcCtD
Emtricitabine—Headache—Topotecan—peripheral nervous system neoplasm	0.000728	0.000761	CcSEcCtD
Emtricitabine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000727	0.00076	CcSEcCtD
Emtricitabine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000727	0.00076	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000727	0.00076	CcSEcCtD
Emtricitabine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000727	0.000759	CcSEcCtD
Emtricitabine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000727	0.000759	CcSEcCtD
Emtricitabine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000726	0.000759	CcSEcCtD
Emtricitabine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000724	0.000756	CcSEcCtD
Emtricitabine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000723	0.000756	CcSEcCtD
Emtricitabine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000723	0.000755	CcSEcCtD
Emtricitabine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000723	0.000755	CcSEcCtD
Emtricitabine—Pain—Vincristine—peripheral nervous system neoplasm	0.00072	0.000752	CcSEcCtD
Emtricitabine—Rash—Melphalan—peripheral nervous system neoplasm	0.000718	0.00075	CcSEcCtD
Emtricitabine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000717	0.000749	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000715	0.000747	CcSEcCtD
Emtricitabine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000708	0.00074	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000707	0.000738	CcSEcCtD
Emtricitabine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000703	0.000735	CcSEcCtD
Emtricitabine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000696	0.000727	CcSEcCtD
Emtricitabine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000695	0.000726	CcSEcCtD
Emtricitabine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000694	0.000725	CcSEcCtD
Emtricitabine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000691	0.000722	CcSEcCtD
Emtricitabine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000691	0.000722	CcSEcCtD
Emtricitabine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000691	0.000722	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000689	0.00072	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000717	CcSEcCtD
Emtricitabine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000717	CcSEcCtD
Emtricitabine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000685	0.000716	CcSEcCtD
Emtricitabine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000685	0.000716	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000679	0.000709	CcSEcCtD
Emtricitabine—Infection—Etoposide—peripheral nervous system neoplasm	0.000678	0.000708	CcSEcCtD
Emtricitabine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000676	0.000707	CcSEcCtD
Emtricitabine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000676	0.000706	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.000705	CcSEcCtD
Emtricitabine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000669	0.000699	CcSEcCtD
Emtricitabine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000668	0.000698	CcSEcCtD
Emtricitabine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000666	0.000696	CcSEcCtD
Emtricitabine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000666	0.000696	CcSEcCtD
Emtricitabine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000664	0.000694	CcSEcCtD
Emtricitabine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000663	0.000692	CcSEcCtD
Emtricitabine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000659	0.000689	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000655	0.000685	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000651	0.00068	CcSEcCtD
Emtricitabine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000645	0.000674	CcSEcCtD
Emtricitabine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000644	0.000673	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000673	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000643	0.000672	CcSEcCtD
Emtricitabine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000637	0.000665	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000663	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000663	CcSEcCtD
Emtricitabine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000657	CcSEcCtD
Emtricitabine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000627	0.000655	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000625	0.000653	CcSEcCtD
Emtricitabine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000621	0.000648	CcSEcCtD
Emtricitabine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000618	0.000646	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000613	0.00064	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.000637	CcSEcCtD
Emtricitabine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000608	0.000636	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000608	0.000636	CcSEcCtD
Emtricitabine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000607	0.000634	CcSEcCtD
Emtricitabine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000604	0.000631	CcSEcCtD
Emtricitabine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000603	0.00063	CcSEcCtD
Emtricitabine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.0006	0.000627	CcSEcCtD
Emtricitabine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.0006	0.000627	CcSEcCtD
Emtricitabine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000599	0.000626	CcSEcCtD
Emtricitabine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000598	0.000625	CcSEcCtD
Emtricitabine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000594	0.000621	CcSEcCtD
Emtricitabine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000616	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000589	0.000615	CcSEcCtD
Emtricitabine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000589	0.000615	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000588	0.000615	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000588	0.000614	CcSEcCtD
Emtricitabine—Pain—Etoposide—peripheral nervous system neoplasm	0.000583	0.00061	CcSEcCtD
Emtricitabine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000609	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000608	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000604	CcSEcCtD
Emtricitabine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.000604	CcSEcCtD
Emtricitabine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000576	0.000602	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000597	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000593	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000588	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000563	0.000588	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000586	CcSEcCtD
Emtricitabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00056	0.000585	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000583	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000558	0.000583	CcSEcCtD
Emtricitabine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000557	0.000582	CcSEcCtD
Emtricitabine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000556	0.000581	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.00058	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.00058	CcSEcCtD
Emtricitabine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000551	0.000576	CcSEcCtD
Emtricitabine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000551	0.000575	CcSEcCtD
Emtricitabine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000549	0.000573	CcSEcCtD
Emtricitabine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.000572	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.00057	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000544	0.000568	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000542	0.000566	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00054	0.000564	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000539	0.000564	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000539	0.000564	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000563	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000562	CcSEcCtD
Emtricitabine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000536	0.000559	CcSEcCtD
Emtricitabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000534	0.000558	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000558	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000555	CcSEcCtD
Emtricitabine—Rash—Vincristine—peripheral nervous system neoplasm	0.000531	0.000555	CcSEcCtD
Emtricitabine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000531	0.000554	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000553	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000553	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000528	0.000551	CcSEcCtD
Emtricitabine—Headache—Vincristine—peripheral nervous system neoplasm	0.000528	0.000551	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000548	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000521	0.000544	CcSEcCtD
Emtricitabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000519	0.000542	CcSEcCtD
Emtricitabine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00051	0.000532	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000503	0.000525	CcSEcCtD
Emtricitabine—Nausea—Vincristine—peripheral nervous system neoplasm	0.0005	0.000523	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.000522	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.00052	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000516	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000514	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00049	0.000511	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000511	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.00051	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000486	0.000508	CcSEcCtD
Emtricitabine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000507	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000483	0.000504	CcSEcCtD
Emtricitabine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000474	0.000495	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000493	CcSEcCtD
Emtricitabine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00047	0.000491	CcSEcCtD
Emtricitabine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000469	0.00049	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000469	0.00049	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000467	0.000488	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000474	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000451	0.000471	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.00047	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000469	CcSEcCtD
Emtricitabine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000442	0.000462	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000456	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000434	0.000453	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000453	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000453	CcSEcCtD
Emtricitabine—Rash—Etoposide—peripheral nervous system neoplasm	0.00043	0.000449	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00043	0.000449	CcSEcCtD
Emtricitabine—Headache—Etoposide—peripheral nervous system neoplasm	0.000427	0.000447	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000438	CcSEcCtD
Emtricitabine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000427	CcSEcCtD
Emtricitabine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000405	0.000423	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000419	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000417	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000417	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000415	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000414	CcSEcCtD
Emtricitabine—Infection—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000397	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000395	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000392	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000391	CcSEcCtD
Emtricitabine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000388	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000386	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000386	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000384	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000383	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000367	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000364	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000363	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000362	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000361	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000359	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000359	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000356	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000352	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000345	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000344	CcSEcCtD
Emtricitabine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000342	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000337	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000334	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000332	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00033	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000327	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000325	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000319	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000319	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000317	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000316	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000316	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000316	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000302	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000294	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000294	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000292	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000292	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000287	CcSEcCtD
Emtricitabine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000283	CcSEcCtD
Emtricitabine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000273	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000272	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000265	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000264	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000262	CcSEcCtD
Emtricitabine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000254	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000253	CcSEcCtD
Emtricitabine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000252	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000252	CcSEcCtD
Emtricitabine—Headache—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00025	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000244	CcSEcCtD
Emtricitabine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000237	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000235	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000233	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000233	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000232	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00022	CcSEcCtD
